Increased activation of mTOR is common in tumors and many normal tissues from obese and/or diabetic mice, and specific mTOR inhibitors block the tumor-enhancing effects of obesity in mouse models (15–, 17). Here, MTOR is linked to obesity due to melanocortin 4 receptor deficiency.